Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $40.1950 (-7.27%) ($40.1950 - $40.1950) on Thu. Mar. 4, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.29% (three month average) | RSI | 20 | Latest Price | $40.1950(-7.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2% a day on average for past five trading days. | Weekly Trend | EDIT declines -11.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(62%) IWC(60%) IBUY(59%) IWM(57%) | Factors Impacting EDIT price | EDIT will decline at least -4.145% in a week (0% probabilities). VIXM(-31%) UUP(-16%) VXX(-13%) TBT(-7%) IGOV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.145% (StdDev 8.29%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $20.34(-49.4%) | Inflection Point | Yes | Resistance Level | $53.39 | 5 Day Moving Average | $44.04(-8.73%) | 10 Day Moving Average | $46.94(-14.37%) | 20 Day Moving Average | $53.39(-24.71%) | To recent high | -55.8% | To recent low | 16% | Market Cap | $2.496b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |